MorphoSys Announces That its Licensee Janssen has Reported That TremfyaR Improves LongTerm PatientReported Outcomes in Patients with Moderate to Severe Plaque Psoriasis news with additional features

DGAPNews MorphoSys AG Key words Study resultsConference13.09.2018 1016 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany September 13 2018MorphoSys Announces That its Licensee Janssen has Reported That TremfyaR I...